Themis Bioscience

company

About

Themis Bioscience is a start-up biotechnology company.

  • 11 - 50

Details

Last Funding Type
Series D
Last Funding Money Raised
€40M
Industries
Biotechnology,Clinical Trials,Health Care
Founded date
Sep 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€40M
Themis Bioscience has raised a total of €40M in funding over 2 rounds. Their latest funding was raised on Sep 18, 2019 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 18, 2019 Series D €40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Themis Bioscience is funded by 1 investors. Merck are the most recent investors.
Investor Name Lead Investor Funding Round
Merck Series D